ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+1.8%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$326M
AUM Growth
+$326M
(-7.8%)
Cap. Flow
-$28.9M
Cap. Flow
% of AUM
-8.87%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
109
New
17
Increased
26
Reduced
40
Closed
25
Top Buys
| 1 |
Sabra Healthcare REIT
SBRA
|
$12.2M |
| 2 |
Danaher
DHR
|
$11.8M |
| 3 |
Pediatrix Medical
MD
|
$7.61M |
| 4 |
Johnson & Johnson
JNJ
|
$7.35M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$6.25M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$8.29M |
| 2 |
UnitedHealth
UNH
|
$6.6M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$6.29M |
| 4 |
iRhythm Technologies
IRTC
|
$6.29M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.24M |
Sector Composition
| 1 | Healthcare | 83.72% |
| 2 | Real Estate | 3.74% |
| 3 | Financials | 3% |
| 4 | Industrials | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
CVS Health
CVS
$92.8B
| $2.24M | 0.68% | 27,500 -20,800 | -43% | -$1.69M |
|
52
Gilead Sciences
GILD
$140B
| $2.22M | 0.67% | 27,357 -72,543 | -73% | -$5.88M |
|
53
Medtronic
MDT
$119B
| $2.16M | 0.65% | 27,739 -11,861 | -30% | -$922K |
|
54
Halozyme
HALO
$8.56B
| $2.01M | 0.61% | 115,500 -21,400 | -16% | -$372K |
|
|
RXDX
55
DELISTED
Ignyta, Inc.
RXDX
| $2M | 0.61% | 161,800 +29,400 | +22% | +$363K |
|
|
AGRX
56
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.97M | 0.6% | +441,708 | New | +$1.97M |
|
|
DERM
57
DELISTED
Dermira, Inc.
DERM
| $1.76M | 0.53% | 65,015 -11,473 | -15% | -$310K |
|
|
ARA
58
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.44M | 0.44% | 95,956 +1,548 | +2% | +$23.2K |
|
59
Baxter International
BAX
$12.7B
| $1.3M | 0.39% | 20,749 +10,849 | +110% | +$681K |
|
60
Edwards Lifesciences
EW
$47.8B
| $1.27M | 0.38% | 11,616 -10,700 | -48% | -$1.17M |
|
61
Zimmer Biomet
ZBH
$21B
| $1.16M | 0.35% | +9,900 | New | +$1.16M |
|
|
ALDR
62
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.12M | 0.34% | 91,600 +49,300 | +117% | +$604K |
|
|
ARRY
63
DELISTED
Array Biopharma Inc
ARRY
| $1.12M | 0.34% | 91,000 +7,300 | +9% | +$89.8K |
|
64
Dynavax Technologies
DVAX
$1.19B
| $1.09M | 0.33% | 50,500 -9,358 | -16% | -$201K |
|
65
Fate Therapeutics
FATE
$120M
| $1.08M | 0.33% | +272,700 | New | +$1.08M |
|
|
WMGI
66
DELISTED
Wright Medical Group Inc
WMGI
| $1.02M | 0.31% | +39,600 | New | +$1.02M |
|
67
Encompass Health
EHC
$12.3B
| $1.01M | 0.31% | 21,804 -9,800 | -31% | -$454K |
|
|
RNTX
68
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $928K | 0.28% | 69,350 -19,750 | -22% | -$264K |
|
69
AnaptysBio
ANAB
$569M
| $860K | 0.26% | +24,600 | New | +$860K |
|
|
BOLD
70
DELISTED
Audentes Therapeutics, Inc
BOLD
| $819K | 0.25% | 29,235 +35 | +0.1% | +$981 |
|
|
NVTA
71
DELISTED
Invitae Corporation
NVTA
| $798K | 0.24% | +85,200 | New | +$798K |
|
|
KITE
72
DELISTED
Kite Pharma, Inc.
KITE
| $737K | 0.22% | 4,100 -12,300 | -75% | -$2.21M |
|
|
ZSAN
73
DELISTED
Zosano Pharma Corporation
ZSAN
| $681K | 0.21% | 827,297 +75,917 | +10% | +$62.5K |
|
74
Ascendis Pharma
ASND
$11.8B
| $628K | 0.19% | +17,330 | New | +$628K |
|
75
Dentsply Sirona
XRAY
$2.85B
| $616K | 0.19% | 10,300 -87,100 | -89% | -$5.21M |
|